The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression
Question Question What impact did the 2004 Food and Drug Administration (FDA) warning regarding antidepressant suicide risk have on the treatment of young people with new onset depression in outpatient settings? Dispensation of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressan...
Gespeichert in:
| Veröffentlicht in: | BMJ mental health 2011-05, Vol.14 (2), p.42-42 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 42 |
|---|---|
| container_issue | 2 |
| container_start_page | 42 |
| container_title | BMJ mental health |
| container_volume | 14 |
| creator | Bridge, Jeffrey A Kelleher, Kelly J |
| description | Question Question What impact did the 2004 Food and Drug Administration (FDA) warning regarding antidepressant suicide risk have on the treatment of young people with new onset depression in outpatient settings? Dispensation of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and other antidepressants was recorded. |
| doi_str_mv | 10.1136/ebmh.14.2.42 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_862792547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>862792547</sourcerecordid><originalsourceid>FETCH-LOGICAL-b388t-2b47f863cc168b7e06ab1f8453fb1f87ac9d2bd135e48f0111e3d8658984c4233</originalsourceid><addsrcrecordid>eNp9kUuP0zAUhS0EYobCjjWyxIINKX7FcZZDh_JQGTYFsbOc5GbqTmMH21HpP-Bn46plkFiwukfXn8651kHoOSVzSrl8A82wmVMxZ3PBHqBLKqQqakm-P8yaS1YQLqoL9CTGLSF5UVaP0QWjJWFUqEv0a70BzAgReHl9hfcmOOtusXfYuGQ7GAPEmCWOk21tZ3Y2HXCw8Q63G-NuocN-SqNJFjKTApg0HFXeJAgu4t4HfPBTthzBjzvAe5s22MG-8C5CwucE691T9Kg3uwjPznOGvi7frRcfitWX9x8XV6ui4UqlgjWi6pXkbUulaiog0jS0V6Lk_XFWpq071nSUlyBUTyilwDslS1Ur0QrG-Qy9OvmOwf-YICY92NjCbmcc-ClqJVlVs1JUmXz5D7n1U3D5OE0rxeta1aTM1OsT1QYfY4Bej8EOJhw0JfpYkD4WpKnQTOf8GXpxNp2aAbp7-E8jGShOgI0Jft6_m3CnZcWrUt98W-j1Z3G9vFl90m___qcZtv-P_g1Dlqlx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783998905</pqid></control><display><type>article</type><title>The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression</title><source>ProQuest Central Essentials</source><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central Student</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central Korea</source><source>ProQuest Central UK/Ireland</source><source>ProQuest Central</source><creator>Bridge, Jeffrey A ; Kelleher, Kelly J</creator><creatorcontrib>Bridge, Jeffrey A ; Kelleher, Kelly J</creatorcontrib><description>Question Question What impact did the 2004 Food and Drug Administration (FDA) warning regarding antidepressant suicide risk have on the treatment of young people with new onset depression in outpatient settings? Dispensation of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and other antidepressants was recorded.</description><identifier>ISSN: 1362-0347</identifier><identifier>EISSN: 1468-960X</identifier><identifier>EISSN: 2755-9734</identifier><identifier>DOI: 10.1136/ebmh.14.2.42</identifier><identifier>PMID: 21502148</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society</publisher><subject>Antidepressants ; Mental depression ; Psychotherapy ; Teenagers</subject><ispartof>BMJ mental health, 2011-05, Vol.14 (2), p.42-42</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b388t-2b47f863cc168b7e06ab1f8453fb1f87ac9d2bd135e48f0111e3d8658984c4233</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1783998905/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1783998905?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,21369,21370,21371,21372,23237,27905,27906,33511,33684,33725,33986,34295,43640,43768,43786,43934,44048,64364,64368,72218,73853,74032,74051,74222,74339</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21502148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bridge, Jeffrey A</creatorcontrib><creatorcontrib>Kelleher, Kelly J</creatorcontrib><title>The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression</title><title>BMJ mental health</title><addtitle>Evid Based Mental Health</addtitle><description>Question Question What impact did the 2004 Food and Drug Administration (FDA) warning regarding antidepressant suicide risk have on the treatment of young people with new onset depression in outpatient settings? Dispensation of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and other antidepressants was recorded.</description><subject>Antidepressants</subject><subject>Mental depression</subject><subject>Psychotherapy</subject><subject>Teenagers</subject><issn>1362-0347</issn><issn>1468-960X</issn><issn>2755-9734</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kUuP0zAUhS0EYobCjjWyxIINKX7FcZZDh_JQGTYFsbOc5GbqTmMH21HpP-Bn46plkFiwukfXn8651kHoOSVzSrl8A82wmVMxZ3PBHqBLKqQqakm-P8yaS1YQLqoL9CTGLSF5UVaP0QWjJWFUqEv0a70BzAgReHl9hfcmOOtusXfYuGQ7GAPEmCWOk21tZ3Y2HXCw8Q63G-NuocN-SqNJFjKTApg0HFXeJAgu4t4HfPBTthzBjzvAe5s22MG-8C5CwucE691T9Kg3uwjPznOGvi7frRcfitWX9x8XV6ui4UqlgjWi6pXkbUulaiog0jS0V6Lk_XFWpq071nSUlyBUTyilwDslS1Ur0QrG-Qy9OvmOwf-YICY92NjCbmcc-ClqJVlVs1JUmXz5D7n1U3D5OE0rxeta1aTM1OsT1QYfY4Bej8EOJhw0JfpYkD4WpKnQTOf8GXpxNp2aAbp7-E8jGShOgI0Jft6_m3CnZcWrUt98W-j1Z3G9vFl90m___qcZtv-P_g1Dlqlx</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>Bridge, Jeffrey A</creator><creator>Kelleher, Kelly J</creator><general>BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110501</creationdate><title>The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression</title><author>Bridge, Jeffrey A ; Kelleher, Kelly J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b388t-2b47f863cc168b7e06ab1f8453fb1f87ac9d2bd135e48f0111e3d8658984c4233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antidepressants</topic><topic>Mental depression</topic><topic>Psychotherapy</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bridge, Jeffrey A</creatorcontrib><creatorcontrib>Kelleher, Kelly J</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ mental health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bridge, Jeffrey A</au><au>Kelleher, Kelly J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression</atitle><jtitle>BMJ mental health</jtitle><addtitle>Evid Based Mental Health</addtitle><date>2011-05-01</date><risdate>2011</risdate><volume>14</volume><issue>2</issue><spage>42</spage><epage>42</epage><pages>42-42</pages><issn>1362-0347</issn><eissn>1468-960X</eissn><eissn>2755-9734</eissn><abstract>Question Question What impact did the 2004 Food and Drug Administration (FDA) warning regarding antidepressant suicide risk have on the treatment of young people with new onset depression in outpatient settings? Dispensation of selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs) and other antidepressants was recorded.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society</pub><pmid>21502148</pmid><doi>10.1136/ebmh.14.2.42</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1362-0347 |
| ispartof | BMJ mental health, 2011-05, Vol.14 (2), p.42-42 |
| issn | 1362-0347 1468-960X 2755-9734 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_862792547 |
| source | ProQuest Central Essentials; ProQuest Central (Alumni Edition); ProQuest Central Student; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central Korea; ProQuest Central UK/Ireland; ProQuest Central |
| subjects | Antidepressants Mental depression Psychotherapy Teenagers |
| title | The 2004 FDA warning on antidepressant suicidality risk changed outpatient treatment patterns for young people with new-onset depression |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%202004%20FDA%20warning%20on%20antidepressant%20suicidality%20risk%20changed%20outpatient%20treatment%20patterns%20for%20young%20people%20with%20new-onset%20depression&rft.jtitle=BMJ%20mental%20health&rft.au=Bridge,%20Jeffrey%20A&rft.date=2011-05-01&rft.volume=14&rft.issue=2&rft.spage=42&rft.epage=42&rft.pages=42-42&rft.issn=1362-0347&rft.eissn=1468-960X&rft_id=info:doi/10.1136/ebmh.14.2.42&rft_dat=%3Cproquest_cross%3E862792547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783998905&rft_id=info:pmid/21502148&rfr_iscdi=true |